Antibacterial Vaccines Market
Antibacterial Vaccines Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antibacterial Vaccines Market Size and Growth
The antibacterial vaccines market is projected to reach USD 9.5 billion by 2028, driven by rising antibiotic resistance, increased infection rates, and growing awareness of vaccine benefits. Market conditions are favorable due to advancements in biotechnology, collaborative research efforts, and increasing public and private funding for vaccine development and distribution.
Companies Covered
(Covid 19 Impact Covered)
◍ Emergent BioDefense Operations Lansing Inc.
◍ Sanofi Pasteur
◍ Merck & Co.
◍ MedImmune LLC
◍ Novartis Vaccines
◍ Diagnostics Ltd.
◍ Intercell Biomedical
◍ MassBiologics
◍ Barr Labs
◍ Inc.
◍ Organon Teknika Co.
◍ GlaxoSmithKline Biologicals
◍ CSL Ltd.
◍ ID Biomedical Co.
◍ Protein Sciences Co.
◍ Wyeth Pharmaceuticals
◍ Inc.
◍ Berna Biotech
The antibacterial vaccines market features key players like Emergent BioDefense, Sanofi Pasteur, and Merck, focusing on R&D, innovative products, and partnerships to enhance vaccine efficacy. Companies contribute through advancements in technology and expanding access, driving market growth. Notable sales figures: Merck - $48 billion, GSK - $43 billion.
Request Sample Report
Market Segmentation
By Application
Bacterial Diseases
Viral Diseases
By Product
◍ Inactivated Vaccines
Conjugate Vaccines ◍ Live/attenuated Vaccines
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
